Any glioma occurring in the midline must include diffuse midline glioma, H3K27-altered, in the differential diagnosis, and as such, H3K27me3, H3K27M and EZHIP IHC need to be included in the diagnostic panel [20,21,24,33,50]. This evidence concerns the gene EZHIP and central nervous system cancer.